Literature DB >> 15961541

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.

Hiroyoshi Nishikawa1, Takuma Kato, Isao Tawara, Tetsushi Takemitsu, Kanako Saito, Linan Wang, Yoshinori Ikarashi, Hiro Wakasugi, Toshinori Nakayama, Masaru Taniguchi, Kagemasa Kuribayashi, Lloyd J Old, Hiroshi Shiku.   

Abstract

We examined the role of CD4+CD25+ regulatory T cells in the development of 3-methylcholanthrene (MCA)-induced tumors. Immunization of wild-type BALB/c mice with a series of SEREX (serological identification of antigens by recombinant expression cloning)-defined broadly expressed self-antigens results in the development of highly active CD4+CD25+ regulatory T cells. Accelerated tumor development was observed in mice immunized with self-antigens and was abolished by antibody-mediated depletion of CD4+ T cells or CD25+ T cells. A similar acceleration of tumorigenesis was also observed in mice adoptively transferred 2 or 4 weeks after MCA injection with CD4+CD25+ T cells derived from mice immunized with DnaJ-like 2, one of these self-antigens. Experiments with Jalpha281-/- mice lacking invariant natural killer (iNK) T cells indicated that iNK T cells, known for their protective role in the development of MCA-induced tumors, were suppressed in immunized hosts. NK cells, also known to play a protective role in MCA induced-tumorigenesis, were also suppressed in mice immunized with serologically defined self-antigens in a CD4+CD25+ T cell-dependent manner. We propose that CD4+CD25+ regulatory T cells generated by immunization with these self-antigens enhance susceptibility to MCA induced-tumorigenesis by down-regulating iNK T and NK reactivity, and suggest that these observations provide direct evidence for the existence of cancer immunosurveillance in this system of chemical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961541      PMCID: PMC1166632          DOI: 10.1073/pnas.0503852102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Authors:  M J Smyth; N Y Crowe; D I Godfrey
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

2.  Regulation of cutaneous malignancy by gammadelta T cells.

Authors:  M Girardi; D E Oppenheim; C R Steele; J M Lewis; E Glusac; R Filler; P Hobby; B Sutton; R E Tigelaar; A C Hayday
Journal:  Science       Date:  2001-09-20       Impact factor: 47.728

Review 3.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

4.  IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Authors:  V Shankaran; H Ikeda; A T Bruce; J M White; P E Swanson; L J Old; R D Schreiber
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

5.  Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.

Authors:  Erika Cretney; Kazuyoshi Takeda; Hideo Yagita; Moira Glaccum; Jacques J Peschon; Mark J Smyth
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

6.  2,5-Di-tert-butyl-1,4-hydroquinone enhances cell transformation accompanied by an increase in intracellular free calcium ion concentration.

Authors:  A Sakai; R Teshima
Journal:  Cancer Lett       Date:  2001-07-26       Impact factor: 8.679

7.  Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.

Authors:  H Nishikawa; K Tanida; H Ikeda; M Sakakura; Y Miyahara; T Aota; K Mukai; M Watanabe; K Kuribayashi; L J Old; H Shiku
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

8.  Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

Authors:  S E Street; E Cretney; M J Smyth
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

9.  Differential tumor surveillance by natural killer (NK) and NKT cells.

Authors:  M J Smyth; K Y Thia; S E Street; E Cretney; J A Trapani; M Taniguchi; T Kawano; S B Pelikan; N Y Crowe; D I Godfrey
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

10.  Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.

Authors:  Hiroyoshi Nishikawa; Takuma Kato; Isao Tawara; Kanako Saito; Hiroaki Ikeda; Kagemasa Kuribayashi; Paul M Allen; Robert D Schreiber; Shimon Sakaguchi; Lloyd J Old; Hiroshi Shiku
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  34 in total

1.  Hsp70 expression and induction as a readout for detection of immune modulatory components in food.

Authors:  Lotte Wieten; Ruurd van der Zee; Renske Goedemans; Jeroen Sijtsma; Mauro Serafini; Nicolette H Lubsen; Willem van Eden; Femke Broere
Journal:  Cell Stress Chaperones       Date:  2009-05-27       Impact factor: 3.667

2.  Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance.

Authors:  Xuefang Cao; Karen Leonard; Lynne I Collins; Sheng F Cai; Joshua C Mayer; Jacqueline E Payton; Michael J Walter; David Piwnica-Worms; Robert D Schreiber; Timothy J Ley
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

Review 3.  Intestinal inflammation and colorectal cancer: a double-edged sword?

Authors:  Angelamaria Rizzo; Francesco Pallone; Giovanni Monteleone; Massimo Claudio Fantini
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

4.  IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.

Authors:  Hanako Ohmatsu; Daniel Humme; Juana Gonzalez; Nicholas Gulati; Markus Möbs; Wolfram Sterry; James G Krueger
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

5.  Type I natural killer T cells suppress tumors caused by p53 loss in mice.

Authors:  Jeremy B Swann; Adam P Uldrich; Serani van Dommelen; Janelle Sharkey; William K Murray; Dale I Godfrey; Mark J Smyth
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

Review 6.  Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 8.  Regulatory T cells in inflammatory bowel diseases and colorectal cancer.

Authors:  Györgyi Műzes; Béla Molnár; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 9.  Regulatory T cells and immune tolerance to tumors.

Authors:  Xuefang Cao
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

10.  Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors.

Authors:  Tae Jung Jang
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.